Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Cleveland BioLabs Company Profile (NASDAQ:CBLI)

Consensus Ratings for Cleveland BioLabs (NASDAQ:CBLI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cleveland BioLabs (NASDAQ:CBLI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/24/2014Cantor FitzgeraldDowngradeBuy -> Hold$4.00 -> $2.00ViewTweet This Rating  Share This Rating on StockTwits
1/24/2014OppenheimerDowngradeOutperform -> Market Perform$0.75 -> $1.13ViewTweet This Rating  Share This Rating on StockTwits
3/20/2013Cantor FitzgeraldInitiated CoverageBuy$4.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 1/25/2013 forward)